(MENAFN) Julphar, Ras Al Khaimah-based pharmaceutical products producer and distributor, reported a 14.9 percent growth in net profit of 2013 to reach USD62.71 million, according to the Emirates 24/7
The company also reported a 15.4 percent growth in revenue year-on-year to reach USD3707 million
Sales boosted by 19.4 percent year-on-year in 2013 driven by the private market sales
Julphar Chairman, Sheikh Faisal Bin Saqr Al Qassimi, said: "The UAE is driving forward healthcare expansion at an international level and Julphar is proud to play a significant role in shaping the future of our industry. As the first and largest Emirati Pharmaceutical Company, we are positioned to help create a truly global platform for quality healthcare.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.